GC tissues; adjacent normal samples; excised tumor tissues
GES-1; HGC-27; AGS
cell line-derived xenograft
glycolysis (promotes); proliferation (promotes); migration (promotes); apoptosis (inhibits); ceRNA regulation (promotes)
RT-qPCR; Transfection; MTT; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; Luciferase Reporter Assay; Bioinformatics Analysis; Clinical Sample Validation; In Vivo Animal Model
circ-NRIP1 was suggested as a promising biomarker for the treatment of GC
In gastric cancer, circ-NRIP1 is up-regulated and promotes proliferation, migration, glycolysis and tumor growth while suppressing apoptosis. Mechanistically, circ-NRIP1 sponges miR-186-5p to increase MYH9 expression, which contributes to glycolytic activation (e.g., HK2/PKM2) and tumor progression.
0.6536
circ-NRIP1 Promotes Glycolysis and Tumor Progression by Regulating miR-186-5p/MYH9 Axis in Gastric Cancer.
combined biological and clinical study